Table 2.

Fluorescence in the tumor and the normal tissues in 19 cases

Case no.	Age	Sex	Tumor size (mm)	Pathology	Administration time of 5-ALA prior to skin incision (hour)	Camera system	Fluorescence of tumor during resection	Fluorescence of tumor in ex vivo (dark box)	Fluorescence of the normal tissue around the tumor in dark box
1	40	M	35	Clear cell carcinoma	6	Olympus	Negative	Negative	Negative
2	76	F	29	Clear cell carcinoma	6	Olympus	Negative	Negative	Negative
3	59	M	33	Clear cell carcinoma	6	Olympus	Negative	Negative	Negative
4	63	M	20	Clear cell carcinoma	0	Olympus	Negative	Negative	Negative
5	71	M	16	Clear cell carcinoma	0	Olympus	Negative	Negative	Negative
6	78	F	36	Clear cell carcinoma	0	Olympus	Negative	Negative	Negative
7	82	M	38	Clear cell carcinoma	12	Olympus	Negative	Negative	Negative
8	52	F	38	Clear cell carcinoma	9	KARL STORZ	Negative	Positive	Negative
9	67	M	22	Clear cell carcinoma	7	KARL STORZ	Negative	Negative	Negative
10	78	F	20	Clear cell carcinoma	9	KARL STORZ	Negative	Negative	Negative
11	58	M	30	Chromophobe carcinoma	0	KARL STORZ	Negative	Negative	Negative
12	61	F	26	Clear cell carcinoma	9	KARL STORZ	Negative	Negative	Negative
13	56	M	14	Clear cell carcinoma	9+0	KARL STORZ	Negative	Positive	Positive
14	57	M	35	Clear cell carcinoma	7	KARL STORZ	Negative	Positive	Positive
15	56	M	50	Clear cell carcinoma	9	KARL STORZ	Positive	Positive	Positive
16	61	M	13	Clear cell carcinoma	7	KARL STORZ	Negative	Positive	Negative
17	71	M	22	Clear cell carcinoma	9	KARL STORZ	Negative	Negative	Negative
18	76	M	40	Chromophobe carcinoma	6	KARL STORZ	Negative	Negative	Negative
19	57	M	35	Clear cell carcinoma	6	KARL STORZ	Negative	Negative	Positive

5-ALA:5-aminolevulinic acid